15 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Article Searches
Will Telephone & Data Systems (TDS) Report Negative Q4 Earnings? What You Should Know https://www.zacks.com/stock/news/2223428/will-telephone-data-systems-tds-report-negative-q4-earnings-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2223428 Feb 08, 2024 - TDS (TDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Telephone and Data Systems, Inc. (TDS) Q4 2023 Earnings Call Transcript https://seekingalpha.com/article/4671101-telephone-and-data-systems-inc-tds-q4-2023-earnings-call-transcript?source=feed_sector_transcripts Feb 16, 2024 - Telephone and Data Systems, Inc. (NYSE:NYSE:TDS) Q4 2023 Earnings Conference Call February 16, 2024 10:00 AM ETCompany ParticipantsColleen Thompson - VP,...
Telephone and Data Systems (TDS) Q4 Loss Narrower Than Expected https://www.zacks.com/stock/news/2227550/telephone-and-data-systems-tds-q4-loss-narrower-than-expected?cid=CS-ZC-FT-analyst_blog|earnings_article-2227550 Feb 16, 2024 - Telephone and Data Systems' (TDS) top line is impeded by declining revenues from the U.S. Cellular vertical. However, growth in TDS Telecom partially reverses this declining trend.
Compared to Estimates, TDS (TDS) Q4 Earnings: A Look at Key Metrics https://www.zacks.com/stock/news/2227587/compared-to-estimates-tds-tds-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2227587 Feb 16, 2024 - While the top- and bottom-line numbers for TDS (TDS) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Compared to Estimates, TD SYNNEX (SNX) Q1 Earnings: A Look at Key Metrics https://www.zacks.com/stock/news/2246078/compared-to-estimates-td-synnex-snx-q1-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2246078 Mar 26, 2024 - Although the revenue and EPS for TD SYNNEX (SNX) give a sense of how its business performed in the quarter ended February 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
TD Cowen ups Stoke to buy on updated data for epilepsy drug https://seekingalpha.com/news/4083718-td-cowen-ups-stoke-to-buy-on-updated-data-for-epilepsy-drug?source=feed_sector_healthcare Mar 26, 2024 - TD Cowen upgraded Stoke Therapeutics (STOK) to buy based on updated Phase 1/2 data for the company’s epilepsy drug candidate STK-001. Read more here.
TD Bank (TD) Rolls Out TD Complete Checking & TD Early Pay https://www.zacks.com/stock/news/2246889/td-bank-td-rolls-out-td-complete-checking-td-early-pay?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2246889 Mar 27, 2024 - TD Bank's (TD) TD Complete Checking and TD Early Pay offerings are set to offer customers convenience and help the company enhance its deposit balance.
TD Bank: Now Is A Good Time To Buy This 5%-Yielding Blue-Chip Deal https://seekingalpha.com/article/4681247-td-bank-good-time-to-buy-5-percent-yielding-blue-chip-deal?source=feed_all_articles Mar 29, 2024 - TD Bank's financial position is vigorous enough to earn upper investment-grade credit ratings from the three major rating agencies. Read why I rate TD stock a buy.
TD Cowen says sickle cell therapies may get higher CMS payments https://seekingalpha.com/news/4089805-td-cowen-says-sickle-cell-therapies-may-get-higher-cms-payments?source=feed_sector_healthcare Apr 15, 2024 - TD Cowen said recently approved gene therapies by Vertex (VRTX)/CRISPR (CRSP) and bluebird bio (BLUE) may get enhanced payments under proposed CMS guidelines. Read more here.
BSAC or TD: Which Is the Better Value Stock Right Now? https://www.zacks.com/stock/news/2260404/bsac-or-td-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2260404 Apr 23, 2024 - BSAC vs. TD: Which Stock Is the Better Value Option?

Pages: 12

Page 1